Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2016-09-23

FDA Approved: CHATEAL EQ — Original Application (Afaxys Pharma, LLC)

View source ↗

Summary

The FDA approved the original application for CHATEAL EQ, a generic fixed-dose combination oral contraceptive containing levonorgestrel and ethinyl estradiol.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CHATEAL EQ (LEVONORGESTREL AND ETHINYL ESTRADIOL)

Snippet

ORIG AP for CHATEAL EQ (LEVONORGESTREL AND ETHINYL ESTRADIOL)